Kiniksa Pharmaceuticals International, plc (KNSA) Form 8-K — Oct 22, 2026
Kiniksa Pharmaceuticals' Compensation Committee appointed Ross Moat as President and Chief Operating Officer, effective immediately. Moat will continue reporting to Chairman and CEO Sanj K. Patel. Moat has been with Kiniksa since June 2019, most recently as EVP, Chief Operating Officer, overseeing commercial, clinical, regulatory and manufacturing operations.
Key figures
- New base salary usd
- 700000
- New target bonus pct
- 60
- Prior base salary usd
- 650000
- Prior target bonus pct
- 55
- Comp increase effective date
- 2027-01-01
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.